Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Demulen, Femulen
Synonyms :
etynodiol
Class :
Oral Contraceptives
Dosage Forms & StrengthsÂ
Tablet Â
0.5 mg Â
Take a dose of 500 mcg orally daily when used as single dose or dose of 1 to 2 mg when used as a combination drug
Not determined Â
Refer to adult dosingÂ
ardeparin: it may decrease the therapeutic efficacy of etynodiol
armodafinil: it may decrease the therapeutic efficacy of etynodiol
asunaprevir: it may decrease the therapeutic efficacy of etynodiol
avanafil: it may increase the therapeutic efficacy of etynodiol
boceprevir: it may decrease the therapeutic efficacy of etynodiol
brexanolone: it may decrease the therapeutic efficacy of etynodiol
budesonide: it may increase the therapeutic efficacy of etynodiol
dabrafenib: it may increase the therapeutic efficacy of etynodiol
dalteparin: it may decrease the therapeutic efficacy of etynodiol
deferasirox: it may decrease the therapeutic efficacy of etynodiol
enoxaparin: it may decrease the therapeutic efficacy of etynodiol
Actions and SpectrumÂ
etynodiol contraceptive effect by inhibiting ovulation. It suppresses the release of gonadotropins from the pituitary gland, which prevents the maturation and release of eggs from the ovaries.
Frequency not defined Â
Menstrual irregularitiesÂ
NauseaÂ
VomitingÂ
Headache Â
DizzinessÂ
Breast discomfortÂ
GynecomastiaÂ
DepressionÂ
Skin disordersÂ
Disturbance of appetiteÂ
Weight changesÂ
Fluid retentionÂ
OedemaÂ
Changes in libido, cholestatic jaundice, hair loss or hirsutismÂ
Black Box WarningÂ
NoneÂ
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
etynodiol suppresses the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. Â
It inhibits the mid-cycle surge of LH, which is necessary for ovulation.Â
PharmacodynamicsÂ
etynodiol thickens cervical mucus, making it more viscous and impeding the passage of sperm through the cervix into the uterus. Â
This change in cervical mucus reduces the chance of sperm reaching and fertilizing an egg.Â
PharmacokineticsÂ
Absorption  Â
etynodiol is well absorbed from the gastrointestinal tract.Â
DistributionÂ
etynodiol is distributed throughout the body.Â
MetabolismÂ
etynodiol undergoes metabolism in the liver.Â
Elimination and excretionÂ
etynodiol is eliminated from the body through urine and feces.Â
AdministrationÂ
etynodiol is taken orally in form of tablets.Â
Patient information leafletÂ
Generic Name: etynodiolÂ
Why do we use etynodiol?Â
etynodiol is primarily used as a contraceptive agent. It is combined with an ethinyl estradiol to form oral contraceptive pills.  Â
Birth control pills containing etynodiol may be used to treat menorrhagia.Â